With Resolution RDC No. 947, Anvisa aims to reduce costs associated with storing and digitizing physical documents, while ensuring the authenticity and integrity of the documents by requiring the use of electronic signatures.
The Medicines Market Monitoring System (Sammed) is open for 2024 H2 marketing report submissions. Meet the March 14, 2025 deadline to qualify for the 2025 drug price adjustment.
The National Health Surveillance Agency (ANVISA) has updated the Reference Drug List, which classifies medications into groups based on their composition.
The European Shortage Monitoring Platform (ESMP), launched on January 29, 2025, enhances the monitoring and management of medicine shortages across the EU. It enables quicker responses and better crisis management in drug unavailability situations.
FDA proposes a new front-of-package nutrition label to help consumers make healthier food choices, focusing on key nutrients like saturated fat, sodium, and added sugars, promoting better public health.
The Pan American Association of Cannabinoid Medicine (APMC) is leading an innovative study on the use of medicinal cannabis in the treatment of osteoporosis and chronic pain in women. The research investigates bone biomarkers and genetic polymorphisms to personalize therapies and expand access to treatment within the SUS.
FDA proposes a new front-of-package nutrition label to help consumers make healthier food choices, focusing on key nutrients like saturated fat, sodium, and added sugars, promoting better public health.
The European Commission has launched a public consultation on medical device regulations. Participate by March 21, 2025, and contribute to their evaluation.
The European Commission has launched a public consultation on medical device regulations. Participate by March 21, 2025, and contribute to their evaluation.
What changes with Anvisa Resolution No. 954? The new regulation, set to take effect on January 21, 2025, introduces adjustments to drug registration, post-registration, and renewal processes, enhancing transparency and sanitary control.
